Healthcare -
Biotechnology - NASDAQ - US
$ 1.565
7.19 %
$ 101 M
Market Cap
-1.01
P/E
INZY - OTHER LONG-TERM ASSETS
Other Long-term Assets INZY - Inozyme Pharma, Inc.
2 M
LAST VALUE
-23.31%
2 YEAR CAGR
126.01%
5 YEAR CAGR
0.00%
10 YEAR CAGR